In 1938, while working with ergot fungus, Swiss chemist Albert Hoffman synthesized lysergic acid diethylamide (LSD). This consciousness-altering substance
Designing non-hallucinogenic psychedelic treatments that may accelerate research on mental health benefits medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
— Presentation entitled BMB-101: A selective 5-HT2C agonist in clinical trials with therapeutic utility — — First-in-human Phase 1 trial for lead program, BMB-101,. | April 10, 2023